A disease-modifying treatment, disease-modifying drug, or disease-modifying therapy is a treatment that delays, slows or reverses the progression of a disease by targeting its underlying cause.[1] They are distinguished from symptomatic treatments that treat the symptoms of a disease but do not address its underlying cause.[2]
Examples
References
- ^ McFarthing, Kevin; Rafaloff, Gary; Baptista, Marco; Mursaleen, Leah; Fuest, Rosie; Wyse, Richard K.; Stott, Simon R.W. (2022-05-24). "Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update". Journal of Parkinson's Disease. 12 (4): 1073–1082. doi:10.3233/JPD-229002. PMC 9198738. PMID 35527571.
- ^ "Symptomatic Versus Disease-Modifying Therapies for Movement Disorders - Parkinson's and Movement Disorder Foundation". pmdf.org. Retrieved 2022-09-11.
This page was last edited on 1 January 2024, at 19:08